PREDICTION OF BIOAVAILABILITY FOR DRUGS WITH A HIGH 1ST-PASS EFFECT USING ORAL CLEARANCE DATA

被引：18

作者：

SOMOGYI, A ^{[1
]}

EICHELBAUM, M ^{[1
]}

GUGLER, R ^{[1
]}

机构：

[1] UNIV BONN,DEPT MED,D-5300 BONN,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 22卷 / 01期

关键词：

D O I：

10.1007/BF00606430

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：85 / 90

页数：6

共 26 条

[21] INFLUENCE OF ROUTE OF ADMINISTRATION ON DRUG AVAILABILITY [J].

ROWLAND, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (01) :70-&

[22] PHYSIOLOGICAL DISPOSITION OF VERAPAMIL IN MAN [J].

SCHOMERUS, M ;

SPIEGELHALDER, B ;

STIEREN, B ;

EICHELBAUM, M .

CARDIOVASCULAR RESEARCH, 1976, 10 (05) :605-612

[23] PHARMACOKINETICS, BIOAVAILABILITY AND ECG RESPONSE OF VERAPAMIL IN PATIENTS WITH LIVER-CIRRHOSIS [J].

SOMOGYI, A ;

ALBRECHT, M ;

KLIEMS, G ;

SCHAFER, K ;

EICHELBAUM, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (01) :51-60

[24]

VESTAL RE, 1979, CLIN PHARMACOL THER, V25, P19

[25]

WALLE T, 1979, CLIN PHARMACOL THER, V26, P167

[26] DIRECT MEASUREMENT OF PROPRANOLOL BIOAVAILABILITY DURING ACCUMULATION TO STEADY-STATE [J].

WOOD, AJJ ;

CARR, K ;

VESTAL, RE ;

BELCHER, S ;

WILKINSON, GR ;

SHAND, DG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (04) :345-350

← 1 2 3 →